GenAI dazzles, but the magic happens in human outcomes
Empowering patients, doctors and policymakers with information. Enabling faster, more personalised information and recommendations to healthcare professionals. Synthesising vast amounts of clinical and RWE into concise insights that highlight public health implications for policymakers. Improving productivity.
GenAI can deliver all this, and it's fundamentally transforming how complex scientific information is accessed and communicated across different audiences.
Key topics of the whitepaper include:
- How GenAI is personalizing scientific communication for patients, healthcare professionals, and policymakers
- Managing the risk of AI hallucinations in clinical settings and high-stakes healthcare decisions
- Implementing explainable AI (XAI) and 'white box' approaches to ensure transparency and auditability
- Combating health misinformation at scale using AI-powered detection and analysis
- Building responsible AI frameworks that balance innovation with safety and compliance
- Measuring ROI and productivity gains from enterprise GenAI deployments
- The future of patient information: from static leaflets to dynamic, AI-powered communications
Download your free whitepaper for exclusive insights from Sanofi, Bayer, MILE, and more! >>>
Key contributors featured in the whitepaper:
- Emmanuel Frenehard, EVP and Chief Digital Officer, Sanofi
- Sai Jasti, Head of Data Science & AI, Bayer Pharmaceutical R&D
- Frits Stulp, Partner, Implement Consulting
- Miena Amiri, MD, Co-founder, Avayl
- Michelle Bridenbaker, VP, Medical Information Leaders in Europe (MILE)
- Koen Nauwelaerts, Regulatory Policy and Science Lead, Bayer
I hope you enjoy the report!
Please let me know if you have any feedback, or if you want to get involved with the event.
Kind regards,
Reuters Events is part of Reuters News & Media Ltd, 5 Canada Square, Canary Wharf, London, E14 5AQ. Registered in England and Wales: 2505735.